Annual ROE
89.61%
+149.85%+248.75%
December 31, 2023
Summary
- As of February 7, 2025, VYGR annual return on equity is 89.61%, with the most recent change of +149.85% (+248.75%) on December 31, 2023.
- During the last 3 years, VYGR annual ROE has risen by +60.66% (+209.53%).
- VYGR annual ROE is now at all-time high.
Performance
VYGR ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
9.12%
+5.62%+160.57%
September 30, 2024
Summary
- As of February 7, 2025, VYGR quarterly return on equity is 9.12%, with the most recent change of +5.62% (+160.57%) on September 30, 2024.
- Over the past year, VYGR quarterly ROE has dropped by -65.43% (-87.77%).
- VYGR quarterly ROE is now -90.94% below its all-time high of 100.61%, reached on March 31, 2023.
Performance
VYGR Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
VYGR ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +248.8% | -87.8% |
| 3 y3 years | +209.5% | +114.5% |
| 5 y5 years | +191.6% | +114.5% |
VYGR ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +248.8% | -90.9% | +113.0% |
| 5 y | 5-year | at high | +248.8% | -90.9% | +112.9% |
| alltime | all time | at high | +106.3% | -90.9% | +100.5% |
Voyager Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 9.12%(+160.6%) |
| Jun 2024 | - | 3.50%(-369.2%) |
| Mar 2024 | - | -1.30%(-101.7%) |
| Dec 2023 | 89.61%(-248.8%) | 74.55%(+108.4%) |
| Sep 2023 | - | 35.78%(-54.1%) |
| Jun 2023 | - | 77.93%(-22.5%) |
| Mar 2023 | - | 100.61%(-260.4%) |
| Dec 2022 | -60.24%(+5.5%) | -62.73%(+192.7%) |
| Sep 2022 | - | -21.43%(-69.3%) |
| Jun 2022 | - | -69.74%(-0.6%) |
| Mar 2022 | - | -70.14%(+15.0%) |
| Dec 2021 | -57.10%(-297.2%) | -61.00%(-14.0%) |
| Sep 2021 | - | -70.89%(-609.6%) |
| Jun 2021 | - | 13.91%(-56.6%) |
| Mar 2021 | - | 32.08%(+0.7%) |
| Dec 2020 | 28.95%(-148.5%) | 31.85%(-15.7%) |
| Sep 2020 | - | 37.78%(-160.3%) |
| Jun 2020 | - | -62.69%(+56.1%) |
| Mar 2020 | - | -40.17%(-12.8%) |
| Dec 2019 | -59.74% | -46.07%(-24.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | -60.96%(-14.4%) |
| Jun 2019 | - | -71.21%(-41.4%) |
| Mar 2019 | - | -121.54%(+17.4%) |
| Dec 2018 | -97.83%(+86.8%) | -103.54%(+24.1%) |
| Sep 2018 | - | -83.41%(+4.4%) |
| Jun 2018 | - | -79.87%(+17.8%) |
| Mar 2018 | - | -67.80%(+11.8%) |
| Dec 2017 | -52.37%(+98.7%) | -60.62%(-1.4%) |
| Sep 2017 | - | -61.47%(+38.9%) |
| Jun 2017 | - | -44.26%(+29.6%) |
| Mar 2017 | - | -34.15%(+31.4%) |
| Dec 2016 | -26.36%(-24.4%) | -25.98%(+17.1%) |
| Sep 2016 | - | -22.19%(+11.2%) |
| Jun 2016 | - | -19.95%(-3.2%) |
| Mar 2016 | - | -20.62%(-34.6%) |
| Dec 2015 | -34.86%(-97.5%) | -31.51%(-19.5%) |
| Sep 2015 | - | -39.13%(-23.8%) |
| Jun 2015 | - | -51.32%(-97.5%) |
| Mar 2015 | - | -2025.41%(+167.6%) |
| Dec 2014 | -1420.10% | -756.74% |
FAQ
- What is Voyager Therapeutics annual return on equity?
- What is the all time high annual ROE for Voyager Therapeutics?
- What is Voyager Therapeutics annual ROE year-on-year change?
- What is Voyager Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Voyager Therapeutics?
- What is Voyager Therapeutics quarterly ROE year-on-year change?
What is Voyager Therapeutics annual return on equity?
The current annual ROE of VYGR is 89.61%
What is the all time high annual ROE for Voyager Therapeutics?
Voyager Therapeutics all-time high annual return on equity is 89.61%
What is Voyager Therapeutics annual ROE year-on-year change?
Over the past year, VYGR annual return on equity has changed by +149.85% (+248.75%)
What is Voyager Therapeutics quarterly return on equity?
The current quarterly ROE of VYGR is 9.12%
What is the all time high quarterly ROE for Voyager Therapeutics?
Voyager Therapeutics all-time high quarterly return on equity is 100.61%
What is Voyager Therapeutics quarterly ROE year-on-year change?
Over the past year, VYGR quarterly return on equity has changed by -65.43% (-87.77%)